American Bio Medica Corporation  (ABMC)
Other Ticker:  


American Bio Medica Corporation

ABMC's Financial Statements and Analysis

American Bio Medica Corporation reported break-eaven for the III. Quarter compare to earnings per share of $0.02 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ 0 $  0 Mill
$-0.02     Unch.     -65.96 %

American Bio Medica's Revenue fell by -65.96 % in III. Quarter (Sep 30 2022) year on year, to $0 million and advanced by 12.97 % sequentially.

American Bio Medica is Expected to report next financial results on April 13, 2023.

More on ABMC's Income Statement

American Bio Medica's in III. Quarter recorded net loss of $-0.314 million, compare to net income of $0.663 million achieved in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-0.400 million realized in previous quarter.

More on ABMC's Growth

Inventories declined by -9.31 % to $0.38 million from III. Quarter a year ago, sequentially inventories fell by -5.24 %. ABMC's Cash flow In III. Quarter company's net cash flow was $0 million

American Bio Medica Corporation does not pay out common stock dividend.

In trailing twelve-month period American Bio Medica Corporation earned $